CERUS CORP

CERS ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2009 FY2008 FY2007 FY2006
Revenue $22.0M $16.8M $12.3M $8.0M
Product Revenue $22.0M $16.8M $11.0M $6.2M
Government Contract Revenue $0 $0 $0 $0
License and Royalty Revenue $0 $0 $1.3M $1.8M
Cost of Revenue $12.6M
Gross Profit $5.4M
Gross Margin 24.5%
Operating Expenses
Research & Development
SG&A Expense $21.9M
Operating Income $-23.8M
Operating Margin -108.3%
Interest Expense $10.0K
Pretax Income
Income Tax Expense
Net Income $-24.1M
Net Margin -109.6%
EPS (Basic) $-0.69
EPS (Diluted) $-0.69
Shares Outstanding (Basic) 34.8M
Shares Outstanding (Diluted) 34.8M
Dividends Per Share
← Newer Page 3 of 3 Older →